IBDEI3BH ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1412,0)
 ;;=TRAUMA/STRESSOR-RELATED DISORDERS^42^115
 ;;^UTILITY(U,$J,358.4,1413,0)
 ;;=SUBSTANCE DISORDER-INHALANT^35^115
 ;;^UTILITY(U,$J,358.4,1414,0)
 ;;=CLINICAL RESEARCH PROGRAM^4^115
 ;;^UTILITY(U,$J,358.4,1415,0)
 ;;=SOMATIC SYMPTOM & RELATED DISORDERS^30^115
 ;;^UTILITY(U,$J,358.4,1416,0)
 ;;=DISRUPTIVE,IMPULSE,CONDUCT D/O^8^115
 ;;^UTILITY(U,$J,358.4,1417,0)
 ;;=ELIMINATION DISORDERS^11^115
 ;;^UTILITY(U,$J,358.4,1418,0)
 ;;=GAMBLING DISORDER^13^115
 ;;^UTILITY(U,$J,358.4,1419,0)
 ;;=OTHER MENTAL DISORDERS^20^115
 ;;^UTILITY(U,$J,358.4,1420,0)
 ;;=NEURODEVELOPMENTAL DISORDERS^18^115
 ;;^UTILITY(U,$J,358.4,1421,0)
 ;;=SUBSTANCE DISORDER-CAFFEINE^32^115
 ;;^UTILITY(U,$J,358.4,1422,0)
 ;;=SUICIDAL IDEATIONS/ATTEMPTS^41^115
 ;;^UTILITY(U,$J,358.4,1423,0)
 ;;=SUBSTANCE DISORDER-UNKNOWN SUBSTANCE^40^115
 ;;^UTILITY(U,$J,358.4,1424,0)
 ;;=SUBSTANCE DISORDER-STIMULANTS^38^115
 ;;^UTILITY(U,$J,358.4,1425,0)
 ;;=UNDERDOSING OF MEDICATION REGIMEN^43^115
 ;;^UTILITY(U,$J,358.4,1426,0)
 ;;=ESTABLISHED PATIENT^1^116
 ;;^UTILITY(U,$J,358.4,1427,0)
 ;;=CONSULTATIONS-OUTPATIENT^3^116
 ;;^UTILITY(U,$J,358.4,1428,0)
 ;;=NEW PATIENT^2^116
 ;;^UTILITY(U,$J,358.4,1429,0)
 ;;=CONSULTATIONS-INPATIENT^4^116
 ;;^UTILITY(U,$J,358.4,1430,0)
 ;;=INITIAL HOSPITAL CARE^5^116
 ;;^UTILITY(U,$J,358.4,1431,0)
 ;;=HOSPITAL CARE DISCHARGE^7^116
 ;;^UTILITY(U,$J,358.4,1432,0)
 ;;=INITIAL OBSERVATION CARE^8^116
 ;;^UTILITY(U,$J,358.4,1433,0)
 ;;=OBSERVATION CARE DISCHARGE SERVICES^10^116
 ;;^UTILITY(U,$J,358.4,1434,0)
 ;;=INPT or OBS ADMIT & DISCHARGE SAME DAY^11^116
 ;;^UTILITY(U,$J,358.4,1435,0)
 ;;=SUBSEQUENT HOSPITAL CARE^6^116
 ;;^UTILITY(U,$J,358.4,1436,0)
 ;;=OBSERVATION SUBSEQUENT CARE^9^116
 ;;^UTILITY(U,$J,358.4,1437,0)
 ;;=DOMICILIARY EST PATIENT^13^116
 ;;^UTILITY(U,$J,358.4,1438,0)
 ;;=DOMICILIARY NEW PATIENT^14^116
 ;;^UTILITY(U,$J,358.4,1439,0)
 ;;=COMMUNITY LIVING CENTER SUBSEQUENT CARE^12^116
 ;;^UTILITY(U,$J,358.4,1440,0)
 ;;=PRESCRIBER CODES^11^117
 ;;^UTILITY(U,$J,358.4,1441,0)
 ;;=PSYCHOTHERAPY (INPT OR OUTPT)^18^117
 ;;^UTILITY(U,$J,358.4,1442,0)
 ;;=OTHER CODES^8^117
 ;;^UTILITY(U,$J,358.4,1443,0)
 ;;=HEALTH/BEHAVIOR ASSESSMENT/INTERVENTION^2^117
 ;;^UTILITY(U,$J,358.4,1444,0)
 ;;=TEAM CONFERENCE^21^117
 ;;^UTILITY(U,$J,358.4,1445,0)
 ;;=INTERACTIVE COMPLEXITY ADD-ON^3^117
 ;;^UTILITY(U,$J,358.4,1446,0)
 ;;=PSYCHIATRIC DIAGNOSTIC EVALUATION^17^117
 ;;^UTILITY(U,$J,358.4,1447,0)
 ;;=PSYCHOTHERAPY FOR CRISIS^19^117
 ;;^UTILITY(U,$J,358.4,1448,0)
 ;;=PROLONGED SERVICES ADD-ON^15^117
 ;;^UTILITY(U,$J,358.4,1449,0)
 ;;=SUBSTANCE USE^20^117
 ;;^UTILITY(U,$J,358.4,1450,0)
 ;;=PREVENTIVE MED COUNSELING^12^117
 ;;^UTILITY(U,$J,358.4,1451,0)
 ;;=OTHER PSYCHOTHERAPY CODES^9^117
 ;;^UTILITY(U,$J,358.4,1452,0)
 ;;=MEDICATIONS^4^117
 ;;^UTILITY(U,$J,358.4,1453,0)
 ;;=NEUROMODULATION^5^117
 ;;^UTILITY(U,$J,358.4,1454,0)
 ;;=NON FTF SERVICES^7^117
 ;;^UTILITY(U,$J,358.4,1455,0)
 ;;=OTHER TESTING SERVICES^10^117
 ;;^UTILITY(U,$J,358.4,1456,0)
 ;;=PREVENTIVE MEDICINE-ESTAB PT^13^117
 ;;^UTILITY(U,$J,358.4,1457,0)
 ;;=PREVENTIVE MEDICINE-NEW PT^14^117
 ;;^UTILITY(U,$J,358.4,1458,0)
 ;;=PROLONGED SVC W/O PT CONTACT^16^117
 ;;^UTILITY(U,$J,358.4,1459,0)
 ;;=NEUROPSYCH TESTING^6^117
 ;;^UTILITY(U,$J,358.4,1460,0)
 ;;=CIH BFA^1^117
 ;;^UTILITY(U,$J,358.4,1461,0)
 ;;=ABUSE,NEGLECT, & VIOLENCE^1^118
 ;;^UTILITY(U,$J,358.4,1462,0)
 ;;=ANXIETY DISORDERS^2^118
